focus -WSS

focus

author：knowledge 2025-09-30 01:14:22 - browse：9

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT Readout Newsletter: Biotech news today

WSS

STAT Readout: Friday, Oct. 20 biotech updates

CDC wastewater surveillance dashboard to track bird flu hotspots

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Sanofi strikes deal with Novavax, boosting the vaccine maker

How AI can help patients find reliable information about doctors

Shionogi licenses Pompe disease therapy from Maze Therapeutics

focus

focus

knowledge

Activists slam private health insurers over coverage restrictions

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Novavax promises a turnaround & Lilly roils the obesity market

STAT Summit: Meghan O’Rourke on making chronic illness visible

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

STAT Summit: How researchers deal with rejection

How to save PrEP access — and even expand it

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Peter Hotez and the public health issue of online harassment

CZI to create biohub to build anti

hotspot

Bird flu outbreak in cows is latest avian flu curveball

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Smaller biotechs seek to piggyback on weight loss drug boom

Elevance, private equity launch primary care company

H5N1 bird flu: what we're starting to learn about infection in cows

Smaller biotechs seek to piggyback on weight loss drug boom

explore

Wikipedia

entertainment

Wikipedia